檢索結果 - Foard, Darren
- Showing 1 - 5 results of 5
-
1
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis 由 Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
出版 2015Text -
2
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis 由 Ravichandran, Sriram, Law, Steven, Mahmood, Shameem, Wisniowski, Brenden, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
出版 2022Text -
3
Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis 由 Manwani, Richa, Foard, Darren, Mahmood, Shameem, Sachchithanantham, Sajitha, Lane, Thirusha, Quarta, Cristina, Youngstein, Taryn, Rezk, Tamer, Lachmann, Helen J, Gillmore, Julian D., Fontana, Marianna, Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh
出版 2018Text -
4
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib 由 Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.
出版 2021Text -
5
Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting 由 Venner, Christopher P., Gillmore, Julian D., Sachchithanantham, Sajitha, Mahmood, Shameem, Lane, Thirusha, Foard, Darren, Roussel, Murielle, Rannigan, Lisa, Gibbs, Simon DJ, Pinney, Jennifer H, Whelan, Carol J., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.
出版 2014Text